Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials

    Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials

    FromOut of the Blue: An AJRCCM Podcast

    Start listeningView podcast show

    Does Nintedanib Benefit Certain Subgroups of IPF Patients More than Others? An Analysis of the Data from the INPULSIS Trials

    FromOut of the Blue: An AJRCCM Podcast

    ratings:
    Length:
    33 minutes
    Released:
    Jan 15, 2016
    Format:
    Podcast episode

    Description

    Dr. Nitin Seam talks with Drs. Ulrich Costabel and Athol Wells about idiopathic pulmonary fibrosis and which patients may benefit from nintedanib treatment. They discuss the INPULSIS trials and Dr. Costabel's article in the January 15 issue of AJRCCM.
    Released:
    Jan 15, 2016
    Format:
    Podcast episode

    Titles in the series (100)

    The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.